tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Revenue

Compare
493 Followers

Fulcrum Therapeutics Revenue

Fulcrum Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 80.00M, Decreased 0.00%. In the fiscal year ending Dec 31, 2024, Fulcrum Therapeutics had annual revenue of 80.00M with 2752.05% growth.
Revenue (ttm)
80.00M
Revenue Growth
3087.25%
P/S Ratio
4.72
Revenue/Employee
$1,777,778
Employees
45
Market Cap
$377.59M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
80.00M77.19M+2,752.05%
Dec 31, 2023
2.81M-3.54M-55.77%
Dec 31, 2022
6.34M-12.82M-66.90%
Dec 31, 2021
19.16M10.34M+117.19%
Dec 31, 2020
8.82M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis